Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipotassium Glycyrrhizinate Emollients in Adult Atopic Dermatitis
NCT06565117Completed
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Oct 2021
- Primary completion
- Feb 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dipotassium glycyrrhizinate in atopic dermatitis (AD) (3 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoints: SCORing Atopic Dermatitis at 8 weeks, Patient-Oriented Eczema Measure at 8 weeks and 3 more. Started Oct 2021; status: completed.
02
Drugs
dipotassium glycyrrhizinate
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT06565117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06565117.